Determining the Plasmodium vivax VCG-1 strain blood stage proteome

Journal of Proteomics

Volumn 113, Issue , 2015, Pages 268-280

  Moreno Perez D A ^a,b,c   Degano R ^c   Ibarrola, N ^c   Muro, A ^c   Patarroyo, M A ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Biology; Mass spectrometry; P. vivax; Proteins; Proteome

Indexed keywords

PROTEOME; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DATA BASE; IN VITRO STUDY; LIFE CYCLE ASSESSMENT; LIQUID CHROMATOGRAPHY; MALARIA; MASS SPECTROMETRY; MOLECULAR GENETICS; NONHUMAN; PARASITE IDENTIFICATION; PARASITE VIRULENCE; PLASMODIUM VIVAX; PRIMATE MODEL; PROTEIN ANALYSIS; PROTEOMICS; PUBLIC HEALTH PROBLEM; RETICULOCYTE;

PLASMODIUM VIVAX;

EID: 84908316303     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.10.003     Document Type: Article

References (111)

1. WHO World malaria report 2013. WHO global malaria programme 2013.
2. Guerra C.A., Howes R.E., Patil A.P., Gething P.W., Van Boeckel T.P., Temperley W.H., et al. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 2010, 4:e774.
3. Genton B., D'Acremont V., Rare L., Baea K., Reeder J.C., Alpers M.P., et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 2008, 5:e127.
4. Tjitra E., Anstey N.M., Sugiarto P., Warikar N., Kenangalem E., Karyana M., et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 2008, 5:e128.
5. Moreno-Perez D.A., Ruiz J.A., Patarroyo M.A. Reticulocytes: Plasmodium vivax target cells. Biol Cell 2013, 105:251-260.
6. Nobrega de Sousa T., Carvalho L.H., Alves de Brito C.F. Worldwide genetic variability of the Duffy binding protein: insights into Plasmodium vivax vaccine development. PLoS One 2011, 6:e22944.
7. Moon S.U., Na B.K., Kang J.M., Kim J.Y., Cho S.H., Park Y.K., et al. Genetic polymorphism and effect of natural selection at domain I of apical membrane antigen-1 (AMA-1) in Plasmodium vivax isolates from Myanmar. Acta Trop 2010, 114:71-75.
8. Urquiza M., Patarroyo M.A., Mari V., Ocampo M., Suarez J., Lopez R., et al. Identification and polymorphism of Plasmodium vivax RBP-1 peptides which bind specifically to reticulocytes. Peptides 2002, 23:2265-2277.
9. Prajapati S.K., Kumari P., Singh O.P. Molecular analysis of reticulocyte binding protein-2 gene in Plasmodium vivax isolates from India. BMC Microbiol 2012, 12:243.
10. Gutierrez A., Vicini J., Patarroyo M.E., Murillo L.A., Patarroyo M.A. Plasmodium vivax: polymorphism in the merozoite surface protein 1 gene from wild Colombian isolates. Exp Parasitol 2000, 95:215-219.
11. Imwong M., Boel M.E., Pagornrat W., Pimanpanarak M., McGready R., Day N.P., et al. The first Plasmodium vivax relapses of life are usually genetically homologous. J Infect Dis 2012, 205:680-683.
12. Hulden L. Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival. Malar J 2011, 10:90.
13. Wertheimer S.P., Barnwell J.W. Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein. Exp Parasitol 1989, 69:340-350.
14. del Portillo H.A., Longacre S., Khouri E., David P.H. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proc Natl Acad Sci U S A 1991, 88:4030-4034.
15. Galinski M.R., Medina C.C., Ingravallo P., Barnwell J.W. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell 1992, 69:1213-1226.
16. Cheng Q., Saul A. Sequence analysis of the apical membrane antigen I (AMA-1) of Plasmodium vivax. Mol Biochem Parasitol 1994, 65:183-187.
17. Black C.G., Barnwell J.W., Huber C.S., Galinski M.R., Coppel R.L. The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite. Mol Biochem Parasitol 2002, 120:215-224.
18. Vargas-Serrato E., Barnwell J.W., Ingravallo P., Perler F.B., Galinski M.R. Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101/ABRA of P. falciparum. Mol Biochem Parasitol 2002, 120:41-52.
19. Perez-Leal O., Sierra A.Y., Barrero C.A., Moncada C., Martinez P., Cortes J., et al. Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation. Biochem Biophys Res Commun 2004, 324:1393-1399.
20. Patarroyo M.A., Perez-Leal O., Lopez Y., Cortes J., Rojas-Caraballo J., Gomez A., et al. Identification and characterisation of the Plasmodium vivax rhoptry-associated protein 2. Biochem Biophys Res Commun 2005, 337:853-859.
21. Jalah R., Sarin R., Sud N., Alam M.T., Parikh N., Das T.K., et al. Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax. Mol Biochem Parasitol 2005, 142:158-169.
22. Perez-Leal O., Sierra A.Y., Barrero C.A., Moncada C., Martinez P., Cortes J., et al. Identifying and characterising the Plasmodium falciparum merozoite surface protein 10 Plasmodium vivax homologue. Biochem Biophys Res Commun 2005, 331:1178-1184.
23. Perez-Leal O., Mongui A., Cortes J., Yepes G., Leiton J., Patarroyo M.A. The Plasmodium vivax rhoptry-associated protein 1. Biochem Biophys Res Commun 2006, 341:1053-1058.
24. Mongui A., Perez-Leal O., Soto S.C., Cortes J., Patarroyo M.A. Cloning, expression, and characterisation of a Plasmodium vivax MSP7 family merozoite surface protein. Biochem Biophys Res Commun 2006, 351:639-644.
25. Mongui A., Perez-Leal O., Rojas-Caraballo J., Angel D.I., Cortes J., Patarroyo M.A. Identifying and characterising the Plasmodium falciparum RhopH3 Plasmodium vivax homologue. Biochem Biophys Res Commun 2007, 358:861-866.
26. Angel D.I., Mongui A., Ardila J., Vanegas M., Patarroyo M.A. The Plasmodium vivax Pv41 surface protein: identification and characterization. Biochem Biophys Res Commun 2008, 377:1113-1117.
27. Mongui A., Angel D.I., Guzman C., Vanegas M., Patarroyo M.A. Characterisation of the Plasmodium vivax Pv38 antigen. Biochem Biophys Res Commun 2008, 376:326-330.
28. Siddiqui A.A., Bora H., Singh N., Dash A.P., Sharma Y.D. Expression, purification, and characterization of the immunological response to a 40-kilodalton Plasmodium vivax tryptophan-rich antigen. Infect Immun 2008, 76:2576-2586.
29. Alam M.T., Bora H., Singh N., Sharma Y.D. High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74). Vaccine 2008, 26:3787-3794.
30. Mongui A., Angel D.I., Gallego G., Reyes C., Martinez P., Guhl F., et al. Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry antigen (Pv34). Vaccine 2009, 28:415-421.
31. Mongui A., Angel D.I., Moreno-Perez D.A., Villarreal-Gonzalez S., Almonacid H., Vanegas M., et al. Identification and characterization of the Plasmodium vivax thrombospondin-related apical merozoite protein. Malar J 2010, 9:283.
32. Moreno-Perez D.A., Mongui A., Soler L.N., Sanchez-Ladino M., Patarroyo M.A. Identifying and characterizing a member of the RhopH1/Clag family in Plasmodium vivax. Gene 2011, 481:17-23.
33. Moreno-Perez D.A., Montenegro M., Patarroyo M.E., Patarroyo M.A. Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1). Malar J 2011, 10:314.
34. Arevalo-Pinzon G., Curtidor H., Patino L.C., Patarroyo M.A. PvRON2, a new Plasmodium vivax rhoptry neck antigen. Malar J 2011, 10:60.
35. Roobsoong W., Roytrakul S., Sattabongkot J., Li J., Udomsangpetch R., Cui L. Determination of the Plasmodium vivax schizont stage proteome. J Proteomics 2011, 74:1701-1710.
36. Bitencourt A.R., Vicentin E.C., Jimenez M.C., Ricci R., Leite J.A., Costa F.T., et al. Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3. PLoS One 2013, 8:e56061.
37. Jiang J., Barnwell J.W., Meyer E.V., Galinski M.R. Plasmodium vivax merozoite surface protein-3 (PvMSP3): expression of an 11 member multigene family in blood-stage parasites. PLoS One 2013, 8:e63888.
38. Moreno-Perez D.A., Areiza-Rojas R., Florez-Buitrago X., Silva Y., Patarroyo M.E., Patarroyo M.A. The GPI-anchored 6-Cys protein Pv12 is present in detergent-resistant microdomains of Plasmodium vivax blood stage schizonts. Protist 2013, 164:37-48.
39. Moreno-Perez D.A., Saldarriaga A., Patarroyo M.A. Characterizing PvARP, a novel Plasmodium vivax antigen. Malar J 2013, 12:165.
40. Wang B., Lu F., Cheng Y., Li J., Ito D., Sattabongkot J., et al. Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax. Parasitol Res 2013, 112:585-593.
41. Arevalo-Pinzon G., Curtidor H., Abril J., Patarroyo M.A. Annotation and characterization of the Plasmodium vivax rhoptry neck protein 4 (PvRON4). Malar J 2013, 12:356.
42. Cheng Y., Wang Y., Ito D., Kong D.H., Ha K.S., Chen J.H., et al. The Plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of P. vivax. Infect Immun 2013, 81:1585-1595.
43. Lu F., Li J., Wang B., Cheng Y., Kong D.H., Cui L., et al. Profiling the humoral immune responses to Plasmodium vivax infection and identification of candidate immunogenic rhoptry-associated membrane antigen (RAMA). J Proteomics 2014, 102C:66-82.
44. Goo Y.K., Seo E.J., Choi Y.K., Shin H.I., Sattabongkot J., Ji S.Y., et al. First characterization of Plasmodium vivax liver stage antigen (PvLSA) using synthetic peptides. Parasit Vectors 2014, 7:64.
45. Patarroyo M.A., Calderon D., Moreno-Perez D.A. Vaccines against Plasmodium vivax: a research challenge. Expert Rev Vaccines 2012, 11:1249-1260.
46. Raza A., Beg M.A. Population genetics and drug resistance markers: an essential for malaria surveillance in Pakistan. J Coll Physicians Surg Pak 2013, 23:878-884.
47. Acharya P., Pallavi R., Chandran S., Dandavate V., Sayeed S.K., Rochani A., et al. Clinical proteomics of the neglected human malarial parasite Plasmodium vivax. PLoS One 2011, 6:e26623.
48. Patarroyo M.E., Bermudez A., Patarroyo M.A. Structural and immunological principles leading to chemically synthesized, multiantigenic, multistage, minimal subunit-based vaccine development. Chem Rev 2011, 111:3459-3507.
49. Patarroyo M.E., Patarroyo M.A. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines. Acc Chem Res 2008, 41:377-386.
50. Restrepo-Montoya D., Becerra D., Carvajal-Patino J.G., Mongui A., Nino L.F., Patarroyo M.E., et al. Identification of Plasmodium vivax proteins with potential role in invasion using sequence redundancy reduction and profile hidden Markov models. PLoS One 2011, 6:e25189.
51. Frech C., Chen N. Genome comparison of human and non-human malaria parasites reveals species subset-specific genes potentially linked to human disease. PLoS Comput Biol 2011, 7:e1002320.
52. Acharya P., Pallavi R., Chandran S., Chakravarti H., Middha S., Acharya J., et al. A glimpse into the clinical proteome of human malaria parasites Plasmodium falciparum and Plasmodium vivax. Proteomics Clin Appl 2009, 3:1314-1325.
53. Chen J.H., Jung J.W., Wang Y., Ha K.S., Lu F., Lim C.S., et al. Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays. J Proteome Res 2011, 9:6479-6489.
54. Lasonder E., Ishihama Y., Andersen J.S., Vermunt A.M., Pain A., Sauerwein R.W., et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 2002, 419:537-542.
55. Ray S., Kamath K.S., Srivastava R., Raghu D., Gollapalli K., Jain R., et al. Serum proteome analysis of vivax malaria: an insight into the disease pathogenesis and host immune response. J Proteomics 2012, 75:3063-3080.
56. Ray S., Renu D., Srivastava R., Gollapalli K., Taur S., Jhaveri T., et al. Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers. PLoS One 2012, 7:e41751.
57. Pico de Coana Y., Rodriguez J., Guerrero E., Barrero C., Rodriguez R., Mendoza M., et al. A highly infective Plasmodium vivax strain adapted to Aotus monkeys: quantitative haematological and molecular determinations useful for P. vivax malaria vaccine development. Vaccine 2003, 21:3930-3937.
58. Sriprawat K., Kaewpongsri S., Suwanarusk R., Leimanis M.L., Lek-Uthai U., Phyo A.P., et al. Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood. Malar J 2009, 8:115.
59. Andrysiak P.M., Collins W.E., Campbell G.H. Concentration of Plasmodium ovale- and Plasmodium vivax-infected erythrocytes from nonhuman primate blood using Percoll gradients. Am J Trop Med Hyg 1986, 35:251-254.
60. Prieto J.H., Koncarevic S., Park S.K., Yates J., Becker K. Large-scale differential proteome analysis in Plasmodium falciparum under drug treatment. PLoS One 2008, 3:e4098.
61. Rappsilber J., Mann M., Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2007, 2:1896-1906.
62. Olsen J.V., de Godoy L.M., Li G., Macek B., Mortensen P., Pesch R., et al. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 2005, 4:2010-2021.
63. Perkins D.N., Pappin D.J., Creasy D.M., Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567.
64. Brosch M., Yu L., Hubbard T., Choudhary J. Accurate and sensitive peptide identification with Mascot Percolator. J Proteome Res 2009, 8:3176-3181.
65. Kall L., Canterbury J.D., Weston J., Noble W.S., MacCoss M.J. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods 2007, 4:923-925.
66. Bozdech Z., Mok S., Hu G., Imwong M., Jaidee A., Russell B., et al. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci U S A 2008, 105:16290-16295.
67. Aurrecoechea C., Brestelli J., Brunk B.P., Dommer J., Fischer S., Gajria B., et al. PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res 2009, 37:D539-D543.
68. Westenberger S.J., McClean C.M., Chattopadhyay R., Dharia N.V., Carlton J.M., Barnwell J.W., et al. A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito. PLoS Negl Trop Dis 2010, 4:e653.
69. Huang da W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1-13.
70. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504.
71. Nakaya A., Katayama T., Itoh M., Hiranuka K., Kawashima S., Moriya Y., et al. KEGG OC: a large-scale automatic construction of taxonomy-based ortholog clusters. Nucleic Acids Res 2013, 41:D353-D357.
72. Petersen T.N., Brunak S., von Heijne G., Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 2011, 8:785-786.
73. Pierleoni A., Martelli P.L., Fariselli P., Casadio R. BaCelLo: a balanced subcellular localization predictor. Bioinformatics 2006, 22:e408-e416.
74. Hunter S., Apweiler R., Attwood T.K., Bairoch A., Bateman A., Binns D., et al. InterPro: the integrative protein signature database. Nucleic Acids Res 2009, 37:D211-D215.
75. Kall L., Krogh A., Sonnhammer E.L. A combined transmembrane topology and signal peptide prediction method. J Mol Biol 2004, 338:1027-1036.
76. Poisson G., Chauve C., Chen X., Bergeron A. FragAnchor: a large-scale predictor of glycosylphosphatidylinositol anchors in eukaryote protein sequences by qualitative scoring. Genomics Proteomics Bioinformatics 2007, 5:121-130.
77. Ansari F.A., Kumar N., Bala Subramanyam M., Gnanamani M., Ramachandran S. MAAP: malarial adhesins and adhesin-like proteins predictor. Proteins 2008, 70:659-666.
78. Florens L., Washburn M.P., Raine J.D., Anthony R.M., Grainger M., Haynes J.D., et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002, 419:520-526.
79. Cowman A.F., Berry D., Baum J. The cellular and molecular basis for malaria parasite invasion of the human red blood cell. J Cell Biol 2012, 198:961-971.
80. Goldberg D.E. Hemoglobin degradation. Curr Top Microbiol Immunol 2005, 295:275-291.
81. Zerial M., McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2001, 2:107-117.
82. Ayong L., Raghavan A., Schneider T.G., Taraschi T.F., Fidock D.A., Chakrabarti D. The longin domain regulates the steady-state dynamics of Sec22 in Plasmodium falciparum. Eukaryot Cell 2009, 8:1330-1340.
83. Lee M.C., Moura P.A., Miller E.A., Fidock D.A. Plasmodium falciparum Sec24 marks transitional ER that exports a model cargo via a diacidic motif. Mol Microbiol 2008, 68:1535-1546.
84. Adisa A., Albano F.R., Reeder J., Foley M., Tilley L. Evidence for a role for a Plasmodium falciparum homologue of Sec31p in the export of proteins to the surface of malaria parasite-infected erythrocytes. J Cell Sci 2001, 114:3377-3386.
85. Pesce E.R., Acharya P., Tatu U., Nicoll W.S., Shonhai A., Hoppe H.C., et al. The Plasmodium falciparum heat shock protein 40, Pfj4, associates with heat shock protein 70 and shows similar heat induction and localisation patterns. Int J Biochem Cell Biol 2008, 40:2914-2926.
86. Muralidharan V., Oksman A., Pal P., Lindquist S., Goldberg D.E. Plasmodium falciparum heat shock protein 110 stabilizes the asparagine repeat-rich parasite proteome during malarial fevers. Nat Commun 2012, 3:1310.
87. Acharya P., Kumar R., Tatu U. Chaperoning a cellular upheaval in malaria: heat shock proteins in Plasmodium falciparum. Mol Biochem Parasitol 2007, 153:85-94.
88. del Portillo H.A., Fernandez-Becerra C., Bowman S., Oliver K., Preuss M., Sanchez C.P., et al. A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax. Nature 2001, 410:839-842.
89. Spielmann T., Gardiner D.L., Beck H.P., Trenholme K.R., Kemp D.J. Organization of ETRAMPs and EXP-1 at the parasite-host cell interface of malaria parasites. Mol Microbiol 2006, 59:779-794.
90. Koenderink J.B., Kavishe R.A., Rijpma S.R., Russel F.G. The ABCs of multidrug resistance in malaria. Trends Parasitol 2010, 26:440-446.
91. Carlton J.M., Adams J.H., Silva J.C., Bidwell S.L., Lorenzi H., Caler E., et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455:757-763.
92. Rodriguez L.E., Curtidor H., Urquiza M., Cifuentes G., Reyes C., Patarroyo M.E. Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design. Chem Rev 2008, 108:3656-3705.
93. Curtidor H., Patino L.C., Arevalo-Pinzon G., Vanegas M., Patarroyo M.E., Patarroyo M.A. Plasmodium falciparum rhoptry neck protein 5 peptides bind to human red blood cells and inhibit parasite invasion. Peptides 2014, 53:210-217.
94. Garcia J., Curtidor H., Pinzon C.G., Vanegas M., Moreno A., Patarroyo M.E. Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family. Vaccine 2009, 27:3953-3962.
95. Zheng C., Han L., Yap C.W., Xie B., Chen Y. Progress and problems in the exploration of therapeutic targets. Drug Discov Today 2006, 11:412-420.
96. Nakanishi M. S-adenosyl-l-homocysteine hydrolase as an attractive target for antimicrobial drugs. Yakugaku Zasshi 2007, 127:977-982.
97. Uyemura S.A., Luo S., Vieira M., Moreno S.N., Docampo R. Oxidative phosphorylation and rotenone-insensitive malate- and NADH-quinone oxidoreductases in Plasmodium yoelii yoelii mitochondria in situ. J Biol Chem 2004, 279:385-393.
98. Skinner-Adams T.S., Stack C.M., Trenholme K.R., Brown C.L., Grembecka J., Lowther J., et al. Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials. Trends Biochem Sci 2010, 35:53-61.
99. Madrid D.C., Ting L.M., Waller K.L., Schramm V.L., Kim K. Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites. J Biol Chem 2008, 283:35899-35907.
100. Pessi G., Kociubinski G., Mamoun C.B. A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation. Proc Natl Acad Sci U S A 2004, 101:6206-6211.
101. Sierra A.Y., Barrero C.A., Rodriguez R., Silva Y., Moncada C., Vanegas M., et al. Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides. Vaccine 2003, 21:4133-4144.
102. Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000-1004.
103. Kolker E., Higdon R., Hogan J.M. Protein identification and expression analysis using mass spectrometry. Trends Microbiol 2006, 14:229-235.
104. Baird J.K. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 2004, 48:4075-4083.
105. Tyagi R.K., Sharma Y.D. Erythrocyte binding activity displayed by a selective group of Plasmodium vivax tryptophan rich antigens is inhibited by patients' antibodies. PLoS One 2012, 7:e50754.
106. Garcia J., Curtidor H., Obando-Martinez A.Z., Vizcaino C., Pinto M., Martinez N.L., et al. Synthetic peptides from conserved regions of the Plasmodium falciparum early transcribed membrane and ring exported proteins bind specifically to red blood cell proteins. Vaccine 2009, 27:6877-6886.
107. Triglia T., Tham W.H., Hodder A., Cowman A.F. Reticulocyte binding protein homologues are key adhesins during erythrocyte invasion by Plasmodium falciparum. Cell Microbiol 2009, 11:1671-1687.
108. Haase S., Cabrera A., Langer C., Treeck M., Struck N., Herrmann S., et al. Characterization of a conserved rhoptry-associated leucine zipper-like protein in the malaria parasite Plasmodium falciparum. Infect Immun 2008, 76:879-887.
109. Counihan N.A., Kalanon M., Coppel R.L., de Koning-Ward T.F. Plasmodium rhoptry proteins: why order is important. Trends Parasitol 2013, 29:228-236.
110. Tonkin M.L., Arredondo S.A., Loveless B.C., Serpa J.J., Makepeace K.A., Sundar N., et al. Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41. J Biol Chem 2013, 288:12805-12817.
111. McCutchan T.F., Dame J.B., Miller L.H., Barnwell J. Evolutionary relatedness of Plasmodium species as determined by the structure of DNA. Science 1984, 225:808-811.